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Background: Bleeding complications are associated with an adverse outcome after PCI. Traditional risk factors for bleedings are age, gender, 
underweight, hypertension and renal impairment. The aim of our study was to identify predictors of bleeding complications in patients with PCI and 
bivalirudin in clinical practice.
Methods: In the IMPROVER registry a total of 3799 patients with PCI treated with bivalirudin in 102 centres in 12 European countries were 
enrolled. Here were report the incidence of bleeding complications in subgroups to be at high risk for bleedings. A multivariate logistic regression 
model was applied to identify independent predicotors of bleedings.
Results: The incidence of bleeding complications is shown in the table 
High risk group Other
Age > 75 (n=921) 2.3 % Age < 75 (n=2868) 1.5 %
Female
(n=1028)
2.8 %
Male
(n=2761)
1.3 %
Weight < 60 kg
(n=222)
3.1 %
Weight > 60 kg
(n=3577)
1.6 %
Diabetes
(n=1040)
1.9 % No diabetes (n=2692) 1.6 %
Renal impair-ment (n=557) 2.5 % Normal renal function (n=3202) 1.6 %
Hypertension
(n=2858)
1.9 %
No hypertension
(n=906)
1.2 %
GP IIb/IIIa
(n=179)
3.3 %
No GP IIb/IIIa
(n=3610)
1.6 %
Sheath size > 7 F
(n=444)
4.3 %
Sheat size < 7 F
(n=3297)
1.4 %
Heparin after PCI (n=1068) 3.5 %
No heparin
(n=2721)
1.0 %
In the multivariate regression analysis revealed female gender (OR 2.3, 95% CI 1.4-3.8), heparin after PCI (OR 3.1, 95% CI 1.9-5.1) and sheath size 
> 7F ( OR ratio 3.1 95% CI 1.8-5.4) as independent predictors of bleeding.
Conclusions: In this real-world registry in patients with PCI and adjunctive therapy with bivalirudin procedural factors such as sheath size and 
heparin after PCI, were associated with an increase in bleeding complications, while other traditional risk factors associated with bleeding with other 
antithrombotic regimens, such as age, diabetes and renal impairment had no impact.
